-
Have you caught wind of the buzz surrounding the exciting new advancements in PH treatments?
Exciting breakthroughs lie ahead for our PH community, from new injectables to innovative transdermal patches. Catch up on the latest news articles from PH News and watch the anticipation for the future grow. Stay tuned for an upcoming column with more details!
Experimental therapy targets PAH-driving serotonin receptor
Corsair raises $23M to support testing of treprostinil skin patch.
mal patches
Approval decision on Yutrepia for PH-ILD expected in JanuaryRemember, research is in the early stages, and these treatments aren’t available yet. Stay optimistic for the future of PH treatments and support ongoing research efforts. Stay tuned for updates!
Have you caught the buzz of these?
-
7 Replies
-
Check out my latest column, where I had the privilege to interview Dr. S. Sahay, a PH specialist from Houston Methodist Hospital!
Dr. Sahay is the co-director of the hospital’s PH Comprehensive Care Program, and he shares valuable insights about potential new treatments for PH.
Dig in this exclusive piece as we dive into the world of cutting-edge options for PH patients. Share your takeaways, and let’s talk about this exciting news!
-
Thanks for the information, Jen!
-
It’s my pleasure, @Vicky Olsen. It’s hopeful for us all in the PH community!💜
How are you doing, my PHriend? We would love a brief update. Are you looking forward to the holidays?
-
-
Thanks so much for keeping us up to date!!
-
Hi, @Sarah Beth Shingler. I apologize for missing your thanks. I saw it today and wanted to let you know that I have shared two new FDA-approved treatments for PH this week.
But yes, we must try to stay updated on all of our treatment options. 💜
How are you feeling this week?
-
-
Jen
Just discovered a new medication for PAH. This came out of the Wall Street Journal:
The drug, which will sell under the name Winrevair, treats a condition called pulmonary arterial hypertension that affects nearly 40,000 people in the U.S. In 2021.
According to the article it specifically treats the causes of PHA, especially like CTEPH. Here is the link. Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives out of the WSJ for the 26th.
I would imagine that Biotech would be aware of it.
Randy
-
Hey @Randolph Reynolds, this is the awaited treatment for sostaracept. I shared the news article from our PH News website a few minutes earlier. The link to that post is below.
You are quick, my PHriend. I am slow after my appointment this morning. But we shared this news and had another treatment approved late Friday. I shared that one, too.
I hope you are doing OK this week and pacing as you pack and prepare for this big move. When is this going to occur again? You know my mind is getting old and forgetful. Hehe.
pulmonaryhypertensionnews.com
And, we are on a roll, FDA approves sotatercept, now Winrevair! - Research and Development - Pulmonary Hypertension News Forums
-
Log in to reply.